Which Is Preferable for Chronic Limb-threatening Ischemia
Advances in Surgery · 2026-09 · 60 (1) · 29-48
DOI: 10.1016/j.yasu.2026.03.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Surgery, 2026-09. Verfasst von Mohammed Hamouda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, UC San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Endovascular Procedures, Ischemia, Vascular Grafting, Chronic Limb-Threatening Ischemia. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Chronic limb-threatening ischemia is the most advanced stage of peripheral arterial disease and typically requires revascularization to prevent limb-loss. The choice of open surgical bypass versus endovascular therapy should be individualized based on patients' anatomy, operative risk, and conduit availability. Patients who are suitable candidates for both bypass and endovascular intervention and have an adequate single-segment great saphenous vein should undergo open surgical bypass based on level 1 evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, Department of Surgery, UC San Diego, La Jolla, CA, USA.
- Division of Vascular and Endovascular Surgery, Department of Surgery, UC San Diego, La Jolla, CA, USA. Electronic address: mmalas@health.ucsd.edu.
Zitieren
APA
Hamouda, M., Yei, K., & Malas, M. B. (2026). Which Is Preferable for Chronic Limb-threatening Ischemia. Advances in Surgery, 60(1), 29-48. https://doi.org/10.1016/j.yasu.2026.03.003
Vancouver
Hamouda M, Yei K, Malas MB. Which Is Preferable for Chronic Limb-threatening Ischemia. Advances in Surgery. 2026;60(1):29-48. doi:10.1016/j.yasu.2026.03.003
BibTeX
@article{Hamouda2026,
author = {Hamouda, Mohammed and Yei, Kevin and Malas, Mahmoud B},
title = {Which Is Preferable for Chronic Limb-threatening Ischemia},
journal = {Advances in Surgery},
year = {2026},
volume = {60},
number = {1},
pages = {29--48},
doi = {10.1016/j.yasu.2026.03.003}
}
EUVIMED